BioSpace News Archive

Bryan Katz joins KCR’s growing executive team to take over as head of commercial strategy and global partnerships

Dr. Hans S. Keirstead, AIVITA’s Chairman and CEO, will present at the following time and location:

OncLive®, the nation’s leading digital resource focused on offering oncology professionals the most current and insightful information they need to provide the best patient care, expands its Strategic Alliance Partnership (SAP) program with the addition of Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS).

Novostia announces that it has been awarded EUR 2.5 million grant from the European Union under the highly competitive Horizon 2020 EIC Accelerator.

MBio Diagnostics today announced two contracts with SRI International to develop tests related to homeland security on the MBio Diagnostics platform technology.

Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced the closing of its underwritten registered public offering of 32,260,000 shares of its common stock, offered at a price to the public of $1.55 per share for gross proceeds of approximately $50.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses.

ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced on January 14 that they have entered into an option agreement for an exclusive license for the development and commercialization of a candidate drug for cervical dysplasia under preclinical development by KinoPharma..

A2A Pharmaceuticals Inc. announced an agreement to design and co-develop oncology drug candidates with Daewoong Pharmaceutical Co., Ltd., a major pharmaceutical company in South Korea, using its proprietary AI-enabled drug discovery platform SCULPT™.

TAI Diagnostics, Inc. announced the publication of “Cell-Free DNA Donor Fraction Analysis in Pediatric and Adult Heart Transplant Patients by Multiplexed Allele-Specific Quantitative PCR: Validation of a Rapid and Highly Sensitive Clinical Test for Stratification of Rejection Probability“ in the January 13, 2020 issue of the journal, PLOS ONE.

Collaboration with Tor Vergata University Hospital of Rome Will Be Used to Discover New Mechanisms and Biomarkers in Cancer